
Ashwani Singla
About Ashwani Singla
Data last updated:
Ashwani Singla is a Whole-Time Director at Curetech Formulations Private Limited (since 2003), Director at Csc Pharmaceuticals Private Limited (since 2021) and Partner at Ralycos Llp (since 2019), and holds 5 more current directorships. The companies operate in Pharma, FMCG and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹121 Cr; the largest is Curetech Formulations Private Limited at ₹83.74 Cr (FY 2024). Earlier, Ashwani Singla was a Director at Healwell Pharmaceuticals Private Limited (2015–2017) and Director at Galen Infrastructure Limited (2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 29 Aug 2003 | 2003 | ₹83.74 Cr (FY 2024) | Active | |
| Director | 24 Mar 2021 | 2021 | ₹35.18 Cr (FY 2024) | Active | |
| Partner | 28 Feb 2019 | 2017 | ₹2.38 Cr (FY 2022) | Active | |
| Additional Director | 04 Apr 2022 | 2020 | ₹2.8 Lakh (FY 2025) | Active | |
| Director | 17 Jul 2025 | 2025 | Active | ||
| Partner | 27 Apr 2024 | 2023 | Active | ||
| Director | 13 Apr 2023 | 2023 | Active | ||
| Director | 12 Dec 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Mar 2015 | 2015 | ₹13,094 (FY 2024) | Active | |
| Director | 30 Mar 2019 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ashwani Singla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sumit Kumar | 02817063 | Curetech Formulations Private Limited | Whole-Time Director |
| Mohit Mittal | 09121373 | Csc Pharmaceuticals Private Limited | Director |
| Manu Wahi | 07920577 | Ralycos Llp , Ellsoak Llp | Designated Partner |
| Rakesh Kumar Wahi | 07920578 | Ralycos Llp , Ellsoak Llp | Designated Partner |
| Bharat Bhushan Jain | 09552738 | Hne Healthcare Private Limited | Additional Director |
| Naresh Jain | 08772723 | Hne Healthcare Private Limited | Director |
| Rakesh Bajaj | 00998185 | Medira Healthcare Limited | Director |
| Santosh Kumar Dudeja | 01389266 | Medira Healthcare Limited | Director |
| Parveen Gupta | 09552708 | Nextmile Industries Private Limited | Director |
| Raj Gill | 10114656 | Nextmile Industries Private Limited | Director |
| Harikishan Pachori | 09821032 | Vanachem Pharma Private Limited | Director |
| Neel Kanth | 02639518 | Vanachem Pharma Private Limited | Director |
| Rajni Sharma | 02639523 | Vanachem Pharma Private Limited | Director |
| Shashi Bhushan | 09821031 | Vanachem Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashwani Singla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashwani Singla
Ashwani Singla currently holds 8 directorships: Curetech Formulations Private Limited (Whole-Time Director, since 29 Aug 2003, revenue ₹83.74 Cr (FY 2024)); Csc Pharmaceuticals Private Limited (Director, since 24 Mar 2021, revenue ₹35.18 Cr (FY 2024)); Ralycos Llp (Partner, since 28 Feb 2019, revenue ₹2.38 Cr (FY 2022)); Hne Healthcare Private Limited (Additional Director, since 04 Apr 2022, revenue ₹2.8 Lakh (FY 2025)); Medira Healthcare Limited (Director, since 17 Jul 2025); and 3 more.
Ashwani Singla was first appointed on 29 Aug 2003 as Whole-Time Director at Curetech Formulations Private Limited. The most recent appointment on record is 17 Jul 2025 at Medira Healthcare Limited.
The 4 current companies of Ashwani Singla that report revenue have a combined latest revenue of ₹121 Cr: Curetech Formulations Private Limited ₹83.74 Cr (FY 2024); Csc Pharmaceuticals Private Limited ₹35.18 Cr (FY 2024); Ralycos Llp ₹2.38 Cr (FY 2022); Hne Healthcare Private Limited ₹2.8 Lakh (FY 2025).
Ashwani Singla held 2 earlier board appointments: Healwell Pharmaceuticals Private Limited (Director, 05 Mar 2015 to 18 Dec 2017); Galen Infrastructure Limited (Director, 30 Mar 2019 to 10 Jun 2019).
The current boards of Ashwani Singla's companies include Sumit Kumar (Curetech Formulations Private Limited), Mohit Mittal (Csc Pharmaceuticals Private Limited), Manu Wahi (Ralycos Llp), Rakesh Kumar Wahi (Ralycos Llp), Bharat Bhushan Jain (Hne Healthcare Private Limited), Naresh Jain (Hne Healthcare Private Limited), among others.